GlassScriptPhysician profile
Kathleen P Hutton
NPI 1164518593
$1,453.67
in general payments reported to CMS, 2019-2025
20 companies · $33.86 in 2025
The $33.86 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $377 · 2020: $189 · 2021: $232 · 2022: $99.68 · 2023: $345 · 2024: $178 · 2025: $33.86.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $556.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $254.05 | 2023-2025 | |
| Epi Health, LLC | $244.77 | 2019-2022 | |
| Allergan, INC. | $187.33 | 2019-2021 | |
| Pfizer INC. | $151.74 | 2022-2023 | |
| Sun Pharmaceutical Industries INC. | $100.27 | 2019-2022 | |
| Galderma Laboratories, L.P. | $66.89 | 2019-2023 | |
| Amgen INC. | $66.39 | 2020-2023 | Otezla |
| Dermira, INC. | $53.26 | 2019-2021 | |
| Revance Therapeutics, INC. | $52.46 | 2024 | Daxxify |
| Biofrontera INC. | $41.28 | 2019 | |
| Almirall LLC | $34.27 | 2023-2025 | Klisyri |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $34.05 | 2019-2020 | |
| Leo Pharma INC. | $28.39 | 2020 | |
| Incyte Corporation | $27.42 | 2023 | Opzelura |
| Vyne Pharmaceuticals INC. | $24.71 | 2020 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Misonix INC | $24.42 | 2021 | |
| Arcutis Biotherapeutics, INC. | $22.72 | 2024 | Zoryve |
| Aclaris Therapeutics, INC. | $21.88 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.37 | 2022 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kathleen Hutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.